A multidisciplinary event focused on breaking down the barriers that prevent nearly half of Minnesota’s eligible patients from receiving essential biomarker testing, testing that is critical to identifying the most effective, personalized treatment options. The Minnesota Biomarker Summit convenes providers from across the state to connect, collaborate, and share practical, real-world strategies for improving access to biomarker testing. Through shared learning and proven solutions, the summit aims to accelerate progress and improve lung cancer outcomes statewide.
Why this matters: Lung cancer survival is improving—but gaps in biomarker testing continue to limit access to optimal care. The five-year U.S. lung cancer survival rate is 29.7%, while Minnesota leads the nation at 33.7%, due in large part to expanded access to biomarker testing and precision medicine. By learning from one another and advancing equitable access to biomarker testing we can continue to close gaps in care and push survival rates even higher.
Date: September 18, 2026
Time: 8 a.m. – 2 p.m.
Location: Twin Cities, MN
Virtual: Virtual attendance available
Registration: FREE
This summit is designed for healthcare professionals involved in lung cancer care including the full multidisciplinary care team; oncologists, primary care providers, and key clinical partners.
Registration Coming SoonAGENDA
Networking Breakfast
Patient Spotlight –Why Advocacy Matters, with Maggie McCloskey, Stage 4 Lung Cancer Survivor
Session 1 – Understanding and Optimizing Current Actionable Lung Cancer Biomarkers in Practice (Advancing Precision Medicine from the perspectives of an oncologist and pathologist)
Session 2 – Implementing Reflexive Biomarker Testing in Your Practice/Clinic/System (Overcoming workflow barriers for timely testing)
Lunch – Optional ‘what we offer’ presentations from top biomarker testing companies
Session 3 – Practical Steps to Overcoming Barriers to Biomarker Testing in your Practice/System
- Policy and Reimbursement Barriers (Understanding the 14 Day Rule, 2025 Minnesota Biomarker Bill, private insurance vs. Medicare coverage, and US Guidelines that don’t keep up with scientific advancements)
- Improving Your Electronic Health Record (to maximize biomarker testing and improve waiting times, developing a NSCLC biomarker code to integrate panels and diagnosis)
- Blood Vs Tissue, or Both?
